Description

Perindopres (perindopril) tablets 4 mg. №30

Ingredients:

Perindopril 4 mg is the active ingredient in Perindopres tablets. Other inactive ingredients include lactose, microcrystalline cellulose, and magnesium stearate.

Dosage:

The recommended dosage of Perindopres tablets is one 4 mg tablet taken orally once a day. It is important to follow the instructions provided by your healthcare provider.

Indications:

Perindopres tablets are indicated for the treatment of hypertension and heart failure. They are also used to improve survival after a heart attack.

Contraindications:

Do not take Perindopres tablets if you are pregnant, have a history of angioedema related to previous ACE inhibitor therapy, or have severe kidney disease.

Directions:

Take Perindopres tablets exactly as prescribed by your doctor. Swallow the tablet whole with a glass of water. It can be taken with or without food.

Scientific Evidence:

Perindopril, the active ingredient in Perindopres tablets, is an ACE inhibitor that has been extensively studied for its efficacy in treating hypertension and heart failure. Clinical trials have shown that Perindopril effectively lowers blood pressure and improves cardiac function in patients with heart failure.

Additional Information:

It is important to regularly monitor your blood pressure while taking Perindopres tablets to ensure they are effectively controlling your hypertension. If you experience any side effects or have concerns about the medication, consult your healthcare provider.

Pharmacological Effects:

Perindopril works by inhibiting the angiotensin-converting enzyme (ACE), which plays a key role in regulating blood pressure and fluid balance in the body. By blocking ACE, Perindopril helps to relax blood vessels, reduce blood pressure, and improve cardiac function.

Clinical Trials and Comparative Effectiveness:

Several clinical trials have compared the effectiveness of Perindopril with other ACE inhibitors and antihypertensive medications. A study published in the European Heart Journal demonstrated that Perindopril was superior to other ACE inhibitors in reducing the risk of cardiovascular events in patients with heart failure.

Overall, the scientific evidence supports the use of Perindopres (perindopril) tablets 4 mg in the management of hypertension, heart failure, and post-myocardial infarction care. It is essential to follow the prescribed dosage and recommendations provided by healthcare professionals for optimal therapeutic outcomes.